pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

1,746 catalysts · 3,603 8k filing · 2,280 grant · 1,746 approval · 1,120 device 510k · 1,000 device adverse event · 821 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 30 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×from 2025-12-08×clear all
type
  • 8k filing3,603
  • grant2,280
  • approval1,746
  • device 510k1,120
  • device adverse event1,000
  • device pma821
device recall
602
  • earnings585
  • recall266
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Dec 8, 2025

    50
    ›Dec 8, 2025approval264d agoWINREVAIR (SOTATERCEPT-CSRK) — FDA approvalsotatercept

    Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

    full page →sotatercept →fda approvals ↗
    ›Dec 8, 2025approval264d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: LANNETT CO INC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 8, 2025approval264d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: LANNETT CO INC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 8, 2025approval264d agoEPINEPHRINE — FDA approvaladrenaline

    Sponsor: AMNEAL. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

    full page →adrenaline →fda approvals ↗
    ›Dec 8, 2025approval264d agoLINEZOLID — FDA approvalHQ Speciality Pharma

    Sponsor: CAPLIN. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Dec 8, 2025approval264d agoESTRADIOL — FDA approvalestradiol ER

    Sponsor: TEVA PHARMS USA INC. Form: INSERT. Route: VAGINAL

    full page →estradiol ER →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoTEVIMBRA (TISLELIZUMAB-JSGR) — FDA approvalBeOne Medicines Ltd.

    Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoTEVIMBRA (TISLELIZUMAB-JSGR) — FDA approvalBeOne Medicines Ltd.

    Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoTEVIMBRA (TISLELIZUMAB-JSGR) — FDA approvalBeOne Medicines Ltd.

    Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoRYSTIGGO (ROZANOLIXIZUMAB-NOLI) — FDA approvalrozanolixizumab

    Sponsor: UCB INC. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →rozanolixizumab →fda approvals ↗
    ›Dec 9, 2025approval263d agoIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalSUMATRIPTAN SUCCINATE

    Sponsor: GLAXOSMITHKLINE. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
    ›Dec 9, 2025approval263d agoRECARBRIO (CILASTATIN SODIUM) — FDA approval(cilastatin sodium + imipenem + relebactam)

    Sponsor: MSD MERCK CO. Form: POWDER. Route: INTRAVENOUS

    full page →(cilastatin sodium + imipenem + relebactam) →fda approvals ↗
    ›Dec 9, 2025approval263d agoTEPYLUTE (THIOTEPA) — FDA approvalSTI Pharma LLC

    Sponsor: SHORLA. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoTEPYLUTE (THIOTEPA) — FDA approvalSTI Pharma LLC

    Sponsor: SHORLA. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoIMITREX (SUMATRIPTAN) — FDA approvalSUMATRIPTAN SUCCINATE

    Sponsor: GLAXOSMITHKLINE. Form: SPRAY. Route: NASAL

    full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
    ›Dec 9, 2025approval263d agoIMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalSUMATRIPTAN SUCCINATE

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
    ›Dec 9, 2025approval263d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: MACLEODS PHARMS LTD. Form: CAPSULE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Dec 9, 2025approval263d agoVECURONIUM BROMIDE — FDA approvalVECURONIUM BROMIDE

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →VECURONIUM BROMIDE →fda approvals ↗
    ›Dec 10, 2025approval262d agoENBREL (ETANERCEPT) — FDA approvalAMGEN INC

    Sponsor: IMMUNEX. Form: SYRINGE

    full page →fda approvals ↗
    ›Dec 10, 2025approval262d agoACTEMRA (TOCILIZUMAB) — FDA approvaltocilizumab

    Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION

    full page →tocilizumab →fda approvals ↗
    ›Dec 10, 2025approval262d agoMOMETASONE FUROATE — FDA approvalFougera Pharmaceuticals Inc

    Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL

    full page →fda approvals ↗
    ›Dec 10, 2025approval262d agoACTEMRA (TOCILIZUMAB) — FDA approvaltocilizumab

    Sponsor: GENENTECH. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS

    full page →tocilizumab →fda approvals ↗
    ›Dec 10, 2025approval262d agoREZZAYO (REZAFUNGIN ACETATE) — FDA approvalrezafungin acetate

    Sponsor: MUNDIPHARMA. Form: POWDER. Route: INTRAVENOUS

    full page →rezafungin acetate →fda approvals ↗
    ›Dec 10, 2025approval262d agoISOPROTERENOL HYDROCHLORIDE — FDA approvalISOPROTERENOL HYDROCHLORIDE

    Sponsor: DEVA HOLDING AS. Form: INJECTABLE. Route: INJECTION

    full page →ISOPROTERENOL HYDROCHLORIDE →fda approvals ↗
    ›Dec 10, 2025approval262d agoBUPRENORPHINE HYDROCHLORIDE — FDA approvalBUPRENORPHINE HYDROCHLORIDE

    Sponsor: SPECGX LLC. Form: TABLET. Route: SUBLINGUAL

    full page →BUPRENORPHINE HYDROCHLORIDE →fda approvals ↗
    ›Dec 10, 2025approval262d agoLOTEPREDNOL ETABONATE AND TOBRAMYCIN (LOTEPREDNOL ETABONATE) — FDA approvalloteprednol etabonate

    Sponsor: ALEMBIC. Form: SUSPENSION/DROPS. Route: OPHTHALMIC

    full page →loteprednol etabonate →fda approvals ↗
    ›Dec 10, 2025approval262d agoTHALLOUS CHLORIDE TL 201 (THALLOUS CHLORIDE TL-201) — FDA approval

    Sponsor: CURIUM. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 10, 2025approval262d agoOMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE) — FDA approvalomeprazole DR

    Sponsor: NOVITIUM PHARMA. Form: FOR SUSPENSION. Route: ORAL

    full page →omeprazole DR →fda approvals ↗
    ›Dec 11, 2025approval261d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: ACTAVIS LABS FL INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 11, 2025approval261d agoTRAMADOL HYDROCHLORIDE — FDA approvalTrigen Laboratories Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 11, 2025approval261d agoACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN) — FDA approvalPERRIGO Co plc

    Sponsor: LNK INTL INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 11, 2025approval261d agoDEFERIPRONE — FDA approvalSenores Pharmaceuticals Inc

    Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 11, 2025approval261d agoBLUJEPA (GEPOTIDACIN MESYLATE) — FDA approvalgepotidacin mesylate

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →gepotidacin mesylate →fda approvals ↗
    ›Dec 11, 2025approval261d agoCABERGOLINE — FDA approvalCABERGOLINE

    Sponsor: INGENUS PHARMS LLC. Form: TABLET. Route: ORAL

    full page →CABERGOLINE →fda approvals ↗
    ›Dec 11, 2025approval261d agoMEROPENEM — FDA approvalHQ Speciality Pharma

    Sponsor: BROOKS STERISCIENCE. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ← prev
    page 1 of 35
    next →
    $ANIP73.85-0.95%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $ANIP73.85-0.95%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $ANIP73.85-0.95%
    $AMRX17.54-2.61%
    $ANIP73.85-0.95%
    $ONC372.61-0.85%
    $ONC372.61-0.85%
    $AMRX17.54-2.61%
    $AMGN439.48-0.20%
    $MRK153.10-2.14%
    $ONC372.61-0.85%
    $IGC0.2670+0.41%
    $PRGO14.48+2.84%